1 / 16

PROFESSIONAL STANDARDS COMMITTEE

Issued on January 17, 2003, by the Institute of Medicine (IOM), this report provides critical guidance on smallpox vaccination, addressing key concerns and outlining strategic recommendations. It emphasizes the importance of a science-based policy for the public health component of national bioterrorism preparedness. The report advocates for cautious progression through vaccination phases, proactive communication tailored for diverse audiences, and clarifies compensation issues related to potential vaccine injuries, ensuring informed consent and understanding among participants.

karyn-stanley
Télécharger la présentation

PROFESSIONAL STANDARDS COMMITTEE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PROFESSIONAL STANDARDS COMMITTEE SMALL POX

  2. INSTITUE OF MEDICINE (IOM) • REPORT ISSUED JANUARY 17, 2003 DETAILING CONCERNS • OUTLINES CONCERNS INVOLVING PHASES OF VACCINATION AS AN ADVISORY BODY TO THE CDC

  3. SPECIFIC RECOMMENDATIONS OF IOM: • HIGHLIGHT UNIQUE NATURE OF SMALLPOX VACCINATION PROGRAM • PART OF A PUBLIC HEALTH COMPONENT OF A NATIONAL BIOTERRORISM PREPAREDNESS POLICY • NEED FOR SCIENCE BASED POLICY

  4. SUGGESTION 2 • PROCEED CAUTIOUSLY • ALLOW CONTINUOUS OPPORTUNITY FOR ADEQUATE ANALYSIS OF PHASE 1 • EMBARK ON PHASE II ONLY AFTER PHASE ONE IS THOROUGHLY ANALYZED

  5. SUGGESTION 3 • PROACTIVE COMMUNICATION, TRAINING, AND EDUCATION • CUSTOMIZED FOR MANY DIVERSE AUDIENCES • INCLUDE ALL POTENTIAL VACCINEES, HEALTH CARE PROVIDERS, AND THE GENERAL PUBLIC

  6. SUGGESTION 4 • DESIGNATE ONE TRUSTED SCIENTIST AS SPOKESPERSON • SHARPEN AND EXPAND COMMUNICATION PLAN • RAPID, TRANSPARENT, AND SUSTAINED CONTACT WITH MEDIA

  7. SPECIFIC ISSUES IDENTIFIED • UNKNOWN RISK/BENEFIT • CDC NEEDS TO COMMUNICATE WHAT WOULD TRIGGER A RECONSIDERATION OF METHODS USED TO PROTECT VACCINEES AND THEIR CONTACTS

  8. SPECIFIC ISSUES IDENTIFIED (CONTINUED) • COMPENSATION • HUGE ISSUE BEING REVIEWED BY CONGRESS • CLARIFICATION OF WORKERS COMPENSATION ISSUES IN RELATION TO RELATED INJURIES AND ILLNESSES

  9. SPECIFIC ISSUES IDENTIFIED (CONTINUED) • TRANSMISSION OF VACCINIA VIRUS NEEDS TO BE ACTIVELY AND VIGOR0USLY REVIEWED

  10. SPECIFIC ISSUES IDENTIFIED (CONTINUED) • VOLUNTARY PARTICIPATION • NEEDS TO BE HIGHLIGHTED • CONSENT FORMS MUST HIGHLIGHT RISK/BENEFIT • CONSENT FORMS MUST HIGHLIGHT ADVERSE REACTION COMPENSATION (OR LACK THEREOF)

  11. SPECIFIC ISSUES IDENTIFIED (CONTINUED) • COMPREHENSION OF PROGRAM CONSENT • NEED TO REVIEW VACCINEES ABILTY TO UNDERSTAND CONSENT FORM • REVISE FORM FOR TARGET POPULATION BEING IMMUNIZED IF NEEDED

  12. SPECIFIC ISSUES IDENTIFIED (CONTINUED) • COLLECTION OF DATA ON WHY INDIVIDUALS REFUSE VACCINATION • OPT OUT FORM • PRE-SCREEN

  13. SPECIFIC ISSUES IDENTIFIED (CONTINUED) • EVALUATION OF STATES ABILITY TO MANAGE ADVERSE REACTIONS • PRIOR TO BEGINNING VACCINATION PROCESS

  14. AAA EFFORTS • WEBSITE INCLUDING COMMENTS PROVIDED TO THE IOM AND RESOURCE SITES • AAA WILL NOT RECOMMEND THAT MEMBERS PARTICIPATE (OR NOT) BASED UPON THE PROGRAM BEING VOLUNTARY AND HIGHLY INDIVIDUALIZED

  15. AAA PROGRESS • LAST WEEK WE PARTICIPATED IN THE SECOND MEETING OF THE IOM LIASION COMMITTEE ON SMALLPOX VACCINATION • EMS AND OTHER FIRST RESPONDERS VOICES CLEARLY HEARD

  16. AAA RESOURCES • WEBSITE LINKS • AAA HOMELAND SECURITY AND BIO-TERRORISM TOOL KIT • CDC • IAFC • IOM • WWW.SMALLPOX.ARMY.MIL

More Related